NovaBridge Biosciences Earnings Per Share Diluted

• NovaBridge Biosciences showed an increase of +89.0% in Earnings Per Share Diluted from 2023 to 2024.
• This data is from NovaBridge Biosciences's annual report (Form 10-K), filed with the SEC on April 3, 2025.
• XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2017 to 2024), NovaBridge Biosciences's Earnings Per Share Diluted has grown by 99.8%.
• Historical annual values: Fiscal year 2024: $0.12 (loss) per share | Fiscal year 2023: $1.09 (loss) per share | Fiscal year 2022: $1.96 (loss) per share | Fiscal year 2021: $13.35 (loss) per share | Fiscal year 2020: $3.00 per share | Fiscal year 2019: $201.19 (loss) per share | Fiscal year 2018: $61.70 (loss) per share | Fiscal year 2017: $51.93 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026